PMID: 10759685Apr 12, 2000Paper

Therapeutic drug monitoring of psychotropic medications

British Journal of Clinical Pharmacology
P B Mitchell

Abstract

Therapeutic drug monitoring (TDM) of a number of psychotropic medications has proven to be of value, enabling minimization of the limitations of considerable genetic variability in their metabolism and the high rates of poor compliance with many psychiatric disorders. Therapeutic ranges have been established for lithium, some of the tricyclic antidepressants, and clozapine. TDM has also been shown to be useful in avoiding toxicity (as many psychotropics have narrow therapeutic indices), particularly that due to interactions with other compounds.

References

Nov 27, 1978·European Journal of Clinical Pharmacology·S VandelR Volmat
Mar 1, 1979·Clinical Pharmacokinetics·S A MontgomeryS Dawling
Jul 20, 1979·Archives of General Psychiatry·K R JamisonF K Goodwin
Jan 30, 1978·JAMA : the Journal of the American Medical Association·E J Levit, W D Holden
Apr 1, 1978·British Medical Journal·J Speirs, S R Hirsch
Oct 1, 1976·Clinical Pharmacology and Therapeutics·V E ZieglerJ T Biggs
May 8, 1992·Journal of Chromatography·R N Gupta
Nov 21, 1992·BMJ : British Medical Journal·J K Aronson, D J Reynolds
Jan 1, 1991·Schizophrenia Bulletin·T Van PuttenN Chabert
Oct 1, 1991·The American Journal of Psychiatry·J J Jeffries
Dec 1, 1991·Archives of General Psychiatry·T SuppesM Tohen
May 1, 1989·The American Journal of Psychiatry·M Schou
Sep 1, 1989·Therapeutic Drug Monitoring·P J Orsulak
Nov 30, 1989·The New England Journal of Medicine·A J GelenbergJ Lavelle
May 1, 1987·Psychiatry Research·R M PostR T Joffe
Jan 1, 1988·Archives of General Psychiatry·R J BaldessariniM H Teicher
Feb 1, 1988·Archives of General Psychiatry·R N GoldenW Z Potter
Dec 1, 1987·Australian and New Zealand Journal of Medicine·C J KilpatrickR F Moulds
Jan 1, 1988·Medical Toxicology and Adverse Drug Experience·A Amdisen
Oct 1, 1987·Journal of Clinical Psychopharmacology·B GellerL G Carr
May 1, 1973·The American Journal of Psychiatry·T B CooperG M Simpson
Jun 1, 1970·The British Journal of Psychiatry : the Journal of Mental Science·J AngstM Schou
Nov 1, 1983·Journal of Affective Disorders·A CoppenK Wood
Dec 1, 1983·Journal of Clinical Psychopharmacology·J L BrowneB M Pfohl
Dec 1, 1982·Archives of General Psychiatry·J C NelsonM B Bowers
Jun 1, 1995·Journal of Clinical Psychopharmacology·H ArthurF Sjöqvist
Apr 1, 1995·British Journal of Clinical Pharmacology·M J ArranzD A Collier
Apr 8, 1995·BMJ : British Medical Journal·P HazellD Henry
Oct 1, 1994·Journal of Clinical Psychopharmacology·D J PalaoE Gonzalez-Monclus
Feb 1, 1995·The American Journal of Psychiatry·M H KronigJ A Lieberman
Jan 1, 1994·European Journal of Clinical Pharmacology·K BrøsenK Skjødt
Apr 1, 1994·Journal of Clinical Pharmacology·J I Javaid
Apr 1, 1994·Journal of Clinical Pharmacology·M E WardL Bailey

❮ Previous
Next ❯

Citations

May 18, 2004·Epilepsy & Behavior : E&B·Janice M Buelow, Michael C Smith
May 31, 2014·Expert Opinion on Drug Discovery·Jacob Peedicayil
Mar 29, 2014·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Yasuhisa NagasakaTakashi Usui
Mar 11, 2006·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·H A G NiederländerG J de Jong
Feb 18, 2014·Journal of Correctional Health Care : the Official Journal of the National Commission on Correctional Health Care·Patricia D Pilkinton, James C Pilkinton
Jul 23, 2003·Journal of Psychopharmacology·Catherine Greenwood-SmithDavid J Castle
Apr 4, 2013·Biomedical Papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia·Milan GrundmannRomana Urinovska
Dec 17, 2002·Pharmazie in unserer Zeit·Sebastian Härtter, Christoph Hiemke
Aug 15, 2018·Journal of Clinical Psychopharmacology·Thomas KocarHeiko Graf
May 24, 2007·Analytical and Bioanalytical Chemistry·Franck Saint-MarcouxPierre Marquet
Mar 5, 2010·Fundamental & Clinical Pharmacology·Michael RougemontPierre Baumann
Dec 12, 2001·Clinical Pharmacokinetics·M H EnsomP Patel
Dec 12, 2001·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·M Gex-FabryL P Balant
Apr 15, 2014·Administration and Policy in Mental Health·Cynthia A FontanellaJohn V Campo
May 22, 2002·Therapeutic Drug Monitoring·Rolf P G Van Heeswijk
Dec 4, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·O O Kirilochev, A R Umerova
Sep 17, 2020·Journal of Psychiatric Practice·Virginia FernandesGregory Chandler
Nov 4, 2009·The Medical Journal of Australia·Simon B Dimmitt, Hans G Stampfer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

British Journal of Clinical Pharmacology
P B Mitchell
Journal of the Medical Association of Thailand = Chotmaihet Thangphaet
Chaveewan RatanajamitItsaree Yanate
© 2022 Meta ULC. All rights reserved